Ready, Set, PrEP
12-6-2019Although more than one million people who are at risk for HIV in the United States could benefit from pre-exposure prophylaxis (PrEP) medications, only a small …
Prevention
HIV Testing, Treatment, Prevention Not Reaching Enough Americans
12-4-2019New analysis shows how far proposed federal efforts must go to end U.S. HIV epidemic.
Ready, Set, PrEP Resources
12-3-2019Ready, Set, PrEP resources are listed below. These items are available for download to use and help spread the word about the benefits of PrEP medications and h…
Pre-Exposure Prophylaxis
12-3-2019PrEP is daily medicine that can reduce your chance of getting HIV. Find out if it’s right for you.
Ending HIV Will Require Optimizing Treatment and Prevention Tools, Say NIH Experts
10-25-2019Commentary Emphasizes Need to Optimally Implement Current Tools and Develop New Interventions
FDA Approves Second Drug to Prevent HIV Infection as Part of Ongoing Efforts to End the HIV Epidemic
10-3-2019The FDA today approved Descovy in at-risk adults and adolescents weighing at least 35kg for HIV-1 pre-exposure prophylaxis (PrEP) to reduce the risk of HIV…
Just Released: CDC Communication Resources
9-3-2019CDC released communication tools and resources that support HIV prevention and help people with HIV stay healthy.
HIV Treatment Advances and Other Final HIV Research Updates from the 2019 IAS Conference on HIV Science
7-25-2019The final HIV research updates from IAS 2019 – treatment updates and prevention options for women and girls.
HIV Prevention Research Updates from the 2019 IAS Conference on HIV Science
7-24-2019HIV prevention research was in the spotlight yesterday at the second full day of presentations at the 10th International AIDS Society Conference on HIV Science.
HIV Research Updates from NIH’s Dr. Carl Dieffenbach at the 10th IAS Conference on HIV Science (IAS 2019)
7-23-2019NIH’s Dr. Carl Dieffenbach shared his first update from the gathering of thousands of HIV researchers from around the globe at IAS 2019.